drugset / Trial / NCT05279651

Ivabradine for Prevention of Myocardial Injury After Noncardiac Surgery Trial (PREVENT-MINS)

NCT05279651

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is a multicentre, randomized controlled trial of ivabradine versus placebo.

Timeline

Start
2022-06-13
Primary completion
2025-04-30
Completion
2026-06-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ivabradine Small molecule 5 mg Oral

Indications